{"nctId":"NCT00609466","briefTitle":"A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy","startDateStruct":{"date":"2007-09"},"conditions":["Bunionectomy","Pain","Postoperative Pain","Acute Pain"],"count":291,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: CG5503 IR"]},{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Morphine"]},{"label":"3","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"CG5503 IR","otherNames":[]},{"name":"Morphine","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male and female subjects between 18 and 80 years of age;\n* Scheduled to undergo primary unilateral first metatarsal bunionectomy;\n* Anesthesiological and surgical procedures performed according to protocol;\n* Moderate or severe baseline pain following bunionectomy on a VRS within 9 hours of termination of the continuous popliteal sciatic block or systemic analgesia;\n* Pain following bunionectomy of at least 4 on an 11-point NRS within 9 hours of termination of the continuous popliteal sciatic block or systemic analgesia; American Society of Anesthesiologists (ASA) classification I-III.\n\nExclusion Criteria:\n\n* History of seizure disorder;\n* History of alcohol, medication or drug dependency, unstable psychological personality requiring intermittent or permanent treatment; severely impaired renal function, moderately or severely impaired hepatic function;\n* Contraindications to, or history of allergy or hypersensitivity to CG5503, oxycodone, morphine, fentanyl hydrocodone, acetaminophen, heparin, or any compound planned to be used during the anesthesia, or their excipients;\n* Pre-operative use within 12h prior to surgery or peri-operative use of non- steroidal anti-inflammatory drugs (NSAIDs);\n* Treated regularly with opioid analgesic or NSAIDs within 30 days prior to screening;","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Sum of Pain Intensity Differences Relative to the Baseline Pain Intensity.","description":"Pain Intensity assessed at predefined time points over a 48 hour period using an 11-point Numeric Rating Scale (NRS) where a score of zero indicates \"no pain\" and a score of ten indicates \"pain as bad as you can imagine\". Differences calculated as \\[baseline-post baseline\\] at each predefined time point. The theoretical maximum range of Sum of pain intensity differences (SPID48) is from -480 (indicative of an increase in pain) to 480 (indicative of a decrease in pain).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"46.2","spread":"130.83"},{"groupId":"OG001","value":"102.5","spread":"153.26"},{"groupId":"OG002","value":"-17.5","spread":"111.27"}]}]}]},{"type":"SECONDARY","title":"Number of Participants Using Rescue Medication","description":"Number of participants who used at least one dose of rescue medication during the 72 hour double blind period.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"62","spread":null},{"groupId":"OG001","value":"46","spread":null},{"groupId":"OG002","value":"82","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Pain Relief (TOTPAR)","description":"Total pain relief (TOTPAR) in the 48 hour period from the first dose of study drug. The subject was to indicate pain relief at rest in response to the following question: How much relief have you had from your starting pain? None = 0, A little = 1, Some = 2, A lot = 3 and Complete = 4. The theoretical maximum range of Total pain relief (TOTPAR)48 is from 0 (indicative of no pain relief) to 192. The higher the value the better the pain relief.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"79.2","spread":"49.63"},{"groupId":"OG001","value":"81.6","spread":"56.30"},{"groupId":"OG002","value":"41.8","spread":"50.88"}]}]}]},{"type":"SECONDARY","title":"Sum of Pain Intensity Differences Over 6 Hours (SPID6) Relative to the Baseline Pain Intensity","description":"Pain Intensity assessed at predefined time points over a 6 hour period using an 11-point Numeric Rating Scale (NRS) where a score of zero indicates \"no pain\" and a score of ten indicates \"pain as bad as you can imagine\". Differences calculated as \\[baseline-post baseline\\] at each predefined time point. The theoretical maximum range of Sum of pain intensity differences (SPID6) is from -60 (indicative of an increase in pain) to 60 (indicative of a decrease in pain).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.0","spread":"13.51"},{"groupId":"OG001","value":"8.0","spread":"15.59"},{"groupId":"OG002","value":"-1.2","spread":"13.10"}]}]}]},{"type":"SECONDARY","title":"Sum of Pain Intensity Differences Over 12 Hours (SPID12) Relative to the Baseline Pain Intensity","description":"Pain Intensity assessed at predefined time points over a 12 hour period using an 11-point Numeric Rating Scale (NRS) where a score of zero indicates \"no pain\" and a score of ten indicates \"pain as bad as you can imagine\". Differences calculated as \\[baseline-post baseline\\] at each predefined time point. The theoretical maximum range of Sum of pain intensity differences (SPID12) is from -120 (indicative of an increase in pain) to 120 (indicative of a decrease in pain).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14.4","spread":"28.89"},{"groupId":"OG001","value":"17.9","spread":"32.12"},{"groupId":"OG002","value":"-4.7","spread":"24.82"}]}]}]},{"type":"SECONDARY","title":"Sum of Pain Intensity Differences Over 24 Hours (SPID24) Relative to the Baseline Pain Intensity","description":"Pain Intensity assessed at predefined time points over a 24 hour period using an 11-point Numeric Rating Scale (NRS) where a score of zero indicates \"no pain\" and a score of ten indicates \"pain as bad as you can imagine\". Differences calculated as \\[baseline-post baseline\\] at each predefined time point. The theoretical maximum range of Sum of pain intensity differences (SPID24) is from -240 (indicative of an increase in pain) to 240 (indicative of a decrease in pain).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.3","spread":"60.17"},{"groupId":"OG001","value":"41.3","spread":"68.96"},{"groupId":"OG002","value":"-10.7","spread":"51.28"}]}]}]},{"type":"SECONDARY","title":"Sum of Pain Intensity Differences Over 72 Hours (SPID72) Relative to the Baseline Pain Intensity","description":"Pain Intensity assessed at predefined time points over a 72 hour period using an 11-point Numeric Rating Scale (NRS) where a score of zero indicates \"no pain\" and a score of ten indicates \"pain as bad as you can imagine\". Differences calculated as \\[baseline-post baseline\\] at each predefined time point. The theoretical maximum range of Sum of pain intensity differences (SPID72) is from -720 (indicative of an increase in pain) to 720 (indicative of a decrease in pain).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"78.4","spread":"212.05"},{"groupId":"OG001","value":"174.1","spread":"242"},{"groupId":"OG002","value":"-19.1","spread":"179.48"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0},"commonTop":["Nausea","Vomiting","Headache","Dizziness","Pruritus"]}}}